Skip to main content
Toggle navigation
Login
Search
Home
Tweets by IDWeek 2023
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Live Streamed
On Demand
Back
Favorite
Facebook
Tweet
Print
Erik J. Deurloo, MSc
F. Hoffmann-La Roche Ltd, Switzerland
Poster(s):
(2126) Safety, Tolerability, and Pharmacokinetics (PK) in Healthy Participants Following Single Dose Administration of Zosurabalpin, a Novel Pathogen-Specific Antibiotic for the Treatment of Serious
Acinetobacter
Infections
Saturday, October 14, 2023
12:15 PM – 1:30 PM
US ET
